December 23, 2025

Equitable AI for DR Detection

World-first platform sets new standard for fair and transparent AI evaluation in diabetic eye screening

The Ophthalmologist

December 15, 2025

A Lasting Imprint

Exposure to gestational diabetes in the womb causes ocular microvascular changes, says new TVST study

The Ophthalmologist

December 01, 2025

Twilight Dark-Adaptation Device Now Available in US

Evoq Technologies receives official FDA registration as a Class I medical device

Ophthalmology Management

April 24, 2025

FDA Rejects Extended Dosing Intervals for Eylea HD

The agency did not agree with Regeneron’s proposal to add dosing intervals greater than every 16 weeks, the maximum interval currently indicated for aflibercept 8 mg injections.

Retinal Physician

February 26, 2025

Integration of Vision Services Remains an Unmet Need in FQHCs

Telemedicine, funding, and provider partnerships can help, researchers say.

Conexiant

January 16, 2025

LA County Fires Prompt Business Recovery Centers to Open

"Business owners can meet face-to-face with specialists to apply for disaster loans and access a wide range of resources to guide them through their recovery."

Optometric Management

April 02, 2025

GLP-1 RAs Evaluated for Long-Term Risk of NAION in Patients With Diabetes

Researchers’ subgroup analyses provide data on increased risks according to timepoint, demographics, and comorbidities.

Conexiant

June 27, 2025

Also in the News…

The Ophthalmologist brings you the top news stories and studies of the week

The Ophthalmologist

June 24, 2025

PER-001 Improves Visual Field in Glaucoma

The implant, which elutes an endothelin receptor antagonist, improved optic nerve structure and function independent of IOP lowering.

Glaucoma Physician